"Pyoderma Gangrenosum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.
| Descriptor ID |
D017511
|
| MeSH Number(s) |
C17.800.695.675 C17.800.862.675 C17.800.893.675
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyoderma Gangrenosum".
Below are MeSH descriptors whose meaning is more specific than "Pyoderma Gangrenosum".
This graph shows the total number of publications written about "Pyoderma Gangrenosum" by people in this website by year, and whether "Pyoderma Gangrenosum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 6 | 1 | 7 |
| 2018 | 11 | 2 | 13 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pyoderma Gangrenosum" by people in Profiles.
-
Case Report of Two Patients With COVID-19 and Sacral Pressure Injuries Associated with Pyoderma Gangrenosum. Adv Skin Wound Care. 2021 Aug 01; 34(8):438-443.
-
Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19. Breast J. 2021 08; 27(8):671-674.
-
Pyoderma gangrenosum in a patient with lipoid proteinosis (Urbach-Wiethe disease). J Eur Acad Dermatol Venereol. 2019 08; 33(8):e293-e295.
-
Pyoderma gangrenosum as first manifestation of Crohn's disease. Tech Coloproctol. 2019 01; 23(1):79-80.
-
New validated diagnostic criteria for pyoderma gangrenosum. J Am Acad Dermatol. 2019 04; 80(4):e87-e88.
-
Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness. Dermatol Ther. 2019 01; 32(1):e12774.
-
Tumor necrosis factor-a inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study. J Am Acad Dermatol. 2019 Apr; 80(4):1141-1143.
-
A dermatologic perspective on autoinflammatory diseases. Clin Exp Rheumatol. 2018 Jan-Feb; 36 Suppl 110(1):32-38.
-
Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatol Int. 2018 Jun; 38(6):1139-1151.
-
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 04 01; 154(4):461-466.